Nuvama Wealth Management Allots 1,38,099 Equity Shares Under ESOP and ESAR Schemes

1 min read Updated on 12 May 2026, 02:48 AM

Reviewed by

Naman SScanX News Team

AI Summary

Nuvama Wealth Management Limited allotted 1,38,099 fully paid-up equity shares of face value Rs. 2 each on May 11, 2026, under its Employee Stock Option Scheme(s) and Employee Stock Appreciation Rights Plan. Following the allotment, the company's total equity share capital increased from 18,20,41,513 shares to 18,21,79,612 shares. The disclosure was made to BSE Limited and the National Stock Exchange of India Ltd. in compliance with Regulation 30, and was signed by Company Secretary and Compliance Officer Sneha Patwardhan.

*this image is generated using AI for illustrative purposes only.

Nuvama Wealth Management Limited announced on May 11, 2026, the allotment of 1,38,099 equity shares to eligible employees following the exercise of stock options and stock appreciation rights under its Employee Stock Option Scheme(s) and Employee Stock Appreciation Rights Plan. The allotment was approved by the company on the same date and disclosed to stock exchanges in compliance with Regulation 30.

Share Capital Expansion

Each allotted share carries a face value of Rs. 2 and is fully paid-up. The allotment has resulted in a corresponding increase in the company's total issued equity share capital. The following table summarises the change in share capital:

Metric:	Details
Shares Allotted:	1,38,099
Face Value per Share:	Rs. 2
Share Capital (Pre-Allotment):	18,20,41,513 equity shares
Share Capital (Post-Allotment):	18,21,79,612 equity shares
Allotment Date:	May 11, 2026
Scheme:	Employee Stock Option Scheme(s) and Employee Stock Appreciation Rights Plan

Regulatory Disclosure

The intimation was filed with BSE Limited and the National Stock Exchange of India Ltd. as required under the applicable listing regulations. The disclosure was signed by Sneha Patwardhan, Company Secretary and Compliance Officer of Nuvama Wealth Management Limited, on May 11, 2026.

How might the continued dilution from employee stock option exercises impact Nuvama Wealth Management's earnings per share trajectory over the next few fiscal years?

What is the remaining unexercised pool of stock options and appreciation rights under Nuvama's existing ESOP schemes, and how could future exercises further affect the share capital?

How does Nuvama's employee equity compensation strategy compare to peers in the Indian wealth management sector, and could it influence talent retention amid increasing competition?

Read Next Article

Nuvama Wealth Management Grants 93,930 Employee Stock Appreciation Rights Under ESAR Plan 2024

2 min read Updated on 12 May 2026, 02:29 AM

Reviewed by

Suketu GScanX News Team

Add as a preferred
source on Google

AI Summary

Nuvama Wealth Management Limited granted 93,930 Employee Stock Appreciation Rights to eligible employees on May 11, 2026, under the Nuvama Wealth Employee Stock Appreciation Rights Plan 2024. The grant, covering not more than 93,930 equity shares, is compliant with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, and is administered by the Nomination and Remuneration Committee. The ESAR price is determined based on the average of daily opening and closing prices over 20 trading days prior to the relevant date. Settled in equity shares upon exercise, the ESARs carry an exercise window of 2 years from the date of vesting.

*this image is generated using AI for illustrative purposes only.

Nuvama Wealth Management Limited announced on May 11, 2026, the grant of 93,930 Employee Stock Appreciation Rights (ESARs) to eligible employees under the 'Nuvama Wealth Employee Stock Appreciation Rights Plan 2024'. The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in accordance with SEBI Master Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Key Details of the ESAR Grant

The grant covers not more than 93,930 equity shares of the company and is compliant with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The following table summarises the key parameters of the grant:

Parameter:	Details
Number of ESARs Granted:	93,930
Total Shares Covered:	Not more than 93,930 equity shares
Grant Date:	May 11, 2026
Plan Name:	Nuvama Wealth Employee Stock Appreciation Rights Plan 2024
ESARs Vested:	Nil
Exercise Period:	2 years from the date of vesting
Administering Body:	Nomination and Remuneration Committee
SEBI Regulations Compliance:	SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021

Pricing Formula and Settlement Terms

The ESAR price for each grant is determined by the Nomination and Remuneration Committee. It is calculated as the average of the daily opening and closing price of the company's equity shares, as quoted on the recognised stock exchange where the trading volume is higher, across each of the 20 trading days immediately prior to the relevant date.

Once vested and exercised, the ESARs entitle the holder to receive appreciation on a specified number of equity shares of the company. Settlement of such appreciation is made in the form of equity shares of the company, upon payment of the exercise price and applicable taxes, in accordance with the terms and conditions of the Plan.

Applicable Disclosures

Since the current disclosure pertains solely to the grant of ESARs, several parameters are not applicable at this stage. These include:

ESARs exercised
Money realised by exercise of ESARs
Total shares arising from exercise of ESARs
ESARs lapsed
Subsequent changes, cancellation, or exercise of ESARs
Diluted earnings per share pursuant to the issue of equity shares on exercise of ESARs

No variation of terms has been reported in connection with this grant. The disclosure was signed by Sneha Patwardhan, Company Secretary and Compliance Officer of Nuvama Wealth Management Limited.

How might the vesting schedule and exercise timeline of these ESARs influence employee retention rates at Nuvama Wealth Management over the next 2-3 years?

Given that settlement is made in equity shares rather than cash, what potential dilution impact could future ESAR exercises have on existing shareholders of Nuvama Wealth Management?

How does Nuvama Wealth Management's ESAR grant size and structure compare to similar employee incentive programs offered by competing wealth management firms in India?